Access cutting-edge chronic urticaria treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.
Access chronic urticaria specialists in Los Angeles at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic urticaria treatment provided free
The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.
Sponsor: Celldex Therapeutics
Check if you qualify for this chronic urticaria clinical trial in Los Angeles, CA
If you're searching for chronic urticaria treatment options in Los Angeles, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic urticaria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.